XML 47 R34.htm IDEA: XBRL DOCUMENT v3.23.2
Summary of Business and Significant Accounting Policies (Details)
1 Months Ended 12 Months Ended
Dec. 31, 2020
USD ($)
$ / shares
shares
Nov. 30, 2020
shares
Apr. 30, 2023
USD ($)
segment
application
shares
Apr. 30, 2022
USD ($)
shares
Apr. 30, 2021
USD ($)
Subsidiary, Sale of Stock [Line Items]          
Reverse stock split ratio, common stock   0.1667      
Deferred offering costs reclassified into stockholders' equity as a reduction of the IPO proceeds $ 7,200,000        
Restricted cash     $ 12,600,000 $ 12,600,000  
Allowance for doubtful accounts     400,000 200,000  
Unbilled receivables     77,600,000 19,900,000  
Long-lived assets, impairment     0 0 $ 0
Goodwill, impairment     0 0 0
Capitalized software costs     3,000,000 3,000,000 0
Amortized capitalized software costs     $ 1,100,000 700,000  
Term of pilot phase     6 months    
Number of applications | application     1    
Deferred costs, sales commissions, amortization period (in years)     5 years    
Accrued liabilities, warranties     $ 0    
Advertising expenses     6,900,000 51,900,000 35,300,000
401(k) matching contributions     $ 0 0 0
Number of operating segments | segment     1    
Pilot Phase, Commitment Term Component One          
Subsidiary, Sale of Stock [Line Items]          
Term of pilot phase     1 year    
Pilot Phase, Commitment Term Component Two          
Subsidiary, Sale of Stock [Line Items]          
Term of pilot phase     2 years    
Pilot Phase, Commitment Term Component Three          
Subsidiary, Sale of Stock [Line Items]          
Term of pilot phase     3 years    
Minimum          
Subsidiary, Sale of Stock [Line Items]          
Property and equipment, useful life (in years)     3 years    
Minimum | Trials          
Subsidiary, Sale of Stock [Line Items]          
Revenue, performance obligation timing     56 days    
Maximum          
Subsidiary, Sale of Stock [Line Items]          
Property and equipment, useful life (in years)     5 years    
Maximum | Trials          
Subsidiary, Sale of Stock [Line Items]          
Revenue, performance obligation timing     112 days    
C3.ai DTI Grants Program          
Subsidiary, Sale of Stock [Line Items]          
Contribution expense     $ 0 $ 11,500,000 $ 2,700,000
IPO          
Subsidiary, Sale of Stock [Line Items]          
Net proceeds received 694,600,000        
Private Placement          
Subsidiary, Sale of Stock [Line Items]          
Net proceeds received $ 150,000,000        
Class A Common Stock          
Subsidiary, Sale of Stock [Line Items]          
Common stock, shares authorized (in shares) | shares   390,000,000 1,000,000,000 1,000,000,000  
Class A Common Stock | IPO          
Subsidiary, Sale of Stock [Line Items]          
Sale of stock, number of shares issued (in shares) | shares 17,825,000        
Sale of stock, shares issued, price per share (in dollars per share) | $ / shares $ 42.00        
Class A Common Stock | Over-Allotment Option          
Subsidiary, Sale of Stock [Line Items]          
Sale of stock, number of shares issued (in shares) | shares 2,325,000        
Class A Common Stock | Private Placement          
Subsidiary, Sale of Stock [Line Items]          
Sale of stock, shares issued, price per share (in dollars per share) | $ / shares $ 42.00        
Class A Common Stock | Private Placement | Spring Creek Capital LLC          
Subsidiary, Sale of Stock [Line Items]          
Sale of stock, number of shares issued (in shares) | shares 2,380,952        
Class A Common Stock | Private Placement | Microsoft Corporation          
Subsidiary, Sale of Stock [Line Items]          
Sale of stock, number of shares issued (in shares) | shares 1,190,476        
Redeemable Convertible Class A-1 Common Stock          
Subsidiary, Sale of Stock [Line Items]          
Shares authorized (in shares) | shares   6,666,667      
Conversion of stock, converted (in shares) | shares 6,666,665        
Conversion ratio 1        
Class B Common Stock          
Subsidiary, Sale of Stock [Line Items]          
Common stock, shares authorized (in shares) | shares   21,000,000 3,500,000 3,500,000  
Preferred Stock          
Subsidiary, Sale of Stock [Line Items]          
Shares authorized (in shares) | shares   233,107,379      
Redeemable Convertible Preferred Stock, Excluding Series A Preferred Stock          
Subsidiary, Sale of Stock [Line Items]          
Conversion of stock, converted (in shares) | shares 33,628,776        
Conversion ratio 1        
Series A Redeemable Convertible Preferred Stock          
Subsidiary, Sale of Stock [Line Items]          
Conversion of stock, converted (in shares) | shares 3,499,992        
Conversion ratio 1